Bioretec Ltd’s half-year report January–June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results
Bioretec Ltd Company announcement 15 August 2024 at 8:00 a.m.This announcement is a summary of Bioretec Ltd’s half-year report January–June 2024. The complete half-year report with tables is attached to this release as a pdf file and available at the company’s web pages at https://bioretec.com/investors/investors-in-english/releases. April–June 2024 in brief · Net sales increased by 68% and amounted to EUR 1,379 thousand (4–6/2023: EUR 820 thousand). · Sales margin (excl. other income) was EUR 1,033 (609) thousand, or 74.9% (74.3%) of net sales. · Profit (loss) for the